MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations

    H. Mayo, A. Negida, M. Ahsan, S. Lageman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: The objective of the study was to identify EEG features associated with cognitive fluctuations in patients with Lewy body dementia (LBD). Background: Cognitive fluctuations…
  • 2025 International Congress

    The Impact of Non-Motor Symptoms on Quality of Life in Early Parkinson’s Disease: A Prospective Study

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the prevalence and severity of non-motor symptoms (NMS) in early Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL).…
  • 2025 International Congress

    Health care inequalities in detection, diagnosis, and treatment of Parkinson’s disease among Hispanic population in Texas.

    P. Bhaya, D. Petrosyan, S. Bitar, R. Adlis, I. Khan, K. Privitt, P. Klein, S. Horn (San Antonio, USA)

    Objective: We aim to compare self-described Hispanic versus non-Hispanic patients in UT Health movement disorders clinic with Parkinson’s disease (PD). Background: San Antonio has a…
  • 2025 International Congress

    IPX203 (ER CD-LD) super-responders: Description of a patient subpopulation reaping extra benefits in dose-response when converting from IR CD-LD

    S. Allard, G. Banisadr, S. Fisher, P. Lewitt (Bridgewater, USA)

    Objective: To generate quantitative data helping dose optimization when converting Parkinson’s disease (PD) patients from IR CD-LD to IPX203. Background: IPX203 is the first extended-release…
  • 2025 International Congress

    Spatiotemporal Gait Norms in Moderate-to-Advanced Parkinson’s Disease

    K. Miller, R. Tripathi, S. Solano, S. Factor, J. Mckay, C. Esper (Atlanta, USA)

    Objective: Understanding gait abnormalities in moderate-to-advanced Parkinson’s disease (PD) is essential to enhance patient mobility and optimize clinical management [1]. This study aims to establish…
  • 2025 International Congress

    Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation

    R. Khamishon, K. Devlin, B. Advisory Board, K. Kang, L. Currens, E. Lu, S. Phelan, E. Choi, S. Willoughby, A. Pantelyat, K. Mills (Baltimore, USA)

    Objective: To describe methodological considerations related to stakeholder engagement in community-based participatory research (CBPR) to create a dance and music-based program (DMBP) for people with…
  • 2025 International Congress

    “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.

    A. Sawal, A. Kumar, A. Singh, K. Alreja, S. Tomar, A. Tiwari (chandigarh, India)

    Objective: To devise a portable skid free mat bearing a combination of patterned and pictographic visual cues for freezing of gait. Background: Freezing of gait…
  • 2025 International Congress

    Enhancing Parkinson’s Nurse Care with AI-Driven Remote Symptom Monitoring

    F. Chmell, P. Lee, M. Sander (München, Germany)

    Objective: This project evaluates how AI-driven continuous monitoring and wearable sensors can support Parkinson’s disease (PD) nurses in optimizing medication schedules, assessing treatment efficacy, and…
  • 2025 International Congress

    Frequency and outcome of PEG tube implantations in hospitalized Parkinson’s disease patients

    R. Burke, T. Mehta, H. Kamo, M. Okun, C. Hess, M. Remz (Gainesville, USA)

    Objective: We aimed to investigate the frequency and outcome of percutaneous endoscopic gastrostomy (PEG) tube implantation in patients with Parkinson’s disease (PD) during United States…
  • 2025 International Congress

    Foscarbidopa/Foslevodopa Therapy Improves Continuous Duration of Good ON Time and Correlated With Quality of Life in People With Parkinson’s Disease

    M. Bouchard, R. Hauser, P. Odin, D. Kern, S. Isaacson, L. Bergmann, L. Harmer, J. Homola, R. Gupta, C. Yan, C. Carroll (North Chicago, USA)

    Objective: To assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on longest consecutive duration of Good and Best ON time and association of…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley